GT BIOPHARMA, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2025-05-28: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2025-05-14; Total offering amount $20,000,000.
- 2018-08-17: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-08-02; Total offering amount $5,140,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2025-05-28 | Rule 506(b) | Equity | 2025-05-14 | $20,000,000 | $0 | $20,000,000 | 2 |
|---|
| 2018-08-17 | Rule 506(b) | Equity | 2018-08-02 | $5,140,000 | $5,140,000 | $0 | 13 |
|---|